|1.||Yang, Chih-Sheng: 1 article (05/2012)|
|2.||Yang, Wen-Jen: 1 article (05/2012)|
|3.||Huang, Chen-Ji: 1 article (05/2012)|
|4.||Chen, Ko-Shao: 1 article (05/2012)|
|5.||Lin, Shuen-Fuh: 1 article (05/2012)|
|6.||Williams, Sally L: 1 article (01/2009)|
|7.||Clemons, Traci E: 1 article (01/2009)|
|8.||Ferrigno, Luigina: 1 article (01/2009)|
|9.||Sperduto, Robert D: 1 article (01/2009)|
|10.||Milton, Roy C: 1 article (01/2009)|
|1.||Metabolic Bone Diseases (Osteopenia)
|2.||Body Weight (Weight, Body)
05/01/2002 - "Groups of five male and female Wistar rats were treated by gavage with 0, 0.01, 0.05 or 0.2 mg/kg body weight of the known synthetic estrogen ethinylestradiol for 28-32 days according to a modified enhanced OECD Test Guideline no. 407 in order to investigate which of the current and/or additional parameters would detect effects on the endocrine system reliably and sensitively and to provide data on intra-laboratory variability. "
04/01/2001 - "Groups of five male and five female Wistar rats were treated by gavage with 0, 1, 10, and 100 mg flutamide/kg body weight for at least 28 days to investigate whether proposed enhancements to the current subacute rodent OECD test guideline no. 407 could be included into the testing routine, which of the current and/or additional parameters would detect endocrine-mediated effects of flutamide reliably and sensitively, and to provide information on intra-laboratory variability. "
01/01/2009 - "The objective of this report is to investigate how a long-term vitamin-mineral supplementation following the US Recommended Daily Intake (RDI) affected the plasma levels of selected nutrients in a subset (No. = 407) of participants in the Italian-American Clinical Trial of Nutritional Supplements and Age-related Cataract (CTNS). "
|1.||Acetic Acid (Vinegar)